Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function.
Lydia DyckHannah PrendevilleMathilde RaverdeauMieszko M WilkRoisín M LoftusAaron DouglasJanet McCormackBruce MoranMichael WilkinsonEvanna L MillsMichael DoughtyAurelie FabreHelen M HeneghanCarel W le RouxAndrew E HoganEdward T ChouchaniDonal O'SheaDonal J BrennanLydia LynchPublished in: The Journal of experimental medicine (2022)
Obesity is one of the leading preventable causes of cancer; however, little is known about the effects of obesity on anti-tumor immunity. Here, we investigated the effects of obesity on CD8 T cells in mouse models and patients with endometrial cancer. Our findings revealed that CD8 T cell infiltration is suppressed in obesity, which was associated with a decrease in chemokine production. Tumor-resident CD8 T cells were also functionally suppressed in obese mice, which was associated with a suppression of amino acid metabolism. Similarly, we found that a high BMI negatively correlated with CD8 infiltration in human endometrial cancer and that weight loss was associated with a complete pathological response in six of nine patients. Moreover, immunotherapy using anti-PD-1 led to tumor rejection in lean and obese mice and partially restored CD8 metabolism and anti-tumor immunity. These findings highlight the suppressive effects of obesity on CD8 T cell anti-tumor immunity, which can partially be reversed by weight loss and/or immunotherapy.
Keyphrases
- weight loss
- endometrial cancer
- bariatric surgery
- metabolic syndrome
- roux en y gastric bypass
- weight gain
- insulin resistance
- gastric bypass
- type diabetes
- high fat diet induced
- glycemic control
- body mass index
- endothelial cells
- end stage renal disease
- obese patients
- amino acid
- adipose tissue
- skeletal muscle
- chronic kidney disease
- mass spectrometry
- emergency department
- patient safety
- body composition
- high resolution
- electronic health record
- bone mineral density
- patient reported outcomes